Low dose esketamine injection after childbirth reduces postpartum depression

A single low dose injection of esketamine given immediately after childbirth reduces major depressive episodes in individuals with depressive symptoms during pregnancy (prenatal depression), finds a clinical trial published by The BMJ today.

Culmination Bio, BillionToOne Partner to Validate Cancer Diagnostics

What You Should Know: Culmination Bio, a data and technology company combining clinical and biospecimen data, announced a partnership with BillionToOne, Inc., a next-generation molecular diagnostics company

April 4, 2024

ChatGPT aids in discovering potential Alzheimer’s treatments through drug repurposing

ChatGPT-4 to identify drug repurposing candidates against Alzheimer’s disease (AD).

February 28, 2024

Novo Nordisk plans new study for CagriSema, targets 2026 submission – Pharmaceutical Technology

Novo Nordisk remains confident in CagriSema’s potential despite underwhelming Phase III results so far. Image credit: Shutterstock/ Kittyfly. Novo Nordisk is planning a new Phase

February 6, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.